Objective: There is growing evidence that nitric oxide (NO) is critically involved in obesity and its clinical consequences like cardiovascular disease, hypertension and diabetes. We hypothesize that NO is already involved in the pathophysiology of juvenile obesity. We here determined the role of NO, its metabolites arginine and citrulline in obese and normal weight children. Design: We investigated 57 obese and 57 normal weight age-and gender-matched juveniles. Various clinical parameters as well as body measurements and intima media thickness were determined. Results: Obese juveniles revealed highly significant alterations in the NO pathway. NOX and citrulline were decreased in obese compared to normal weight juveniles and negatively correlated with body weight. Arginine was increased in obese juveniles and positively correlated with body weight. We found a significant negative correlation between NOX and oxidized low-density lipoprotein. Analysis of g-aminobutyric acid (GABA) revealed correlations with the NO pathway as NOX and citrulline were negatively correlated with GABA and arginine showed a positive correlation. Conclusion: We show here that NO and its metabolites arginine and citrulline are already involved in juvenile obesity that may contribute to atherogenesis via reduced bioavailability of NO. Moreover, we identify GABA as a new parameter in the mechanism of obesity-related NO reduction.
Introduction
Nitric oxide (NO) is a potent regulator of vasomotor tone and an important antiatherogenic molecule. These antiatherogenic effects include the regulation of endotheliumdependent vasodilatation, inhibition of smooth muscle cell proliferation and modulation of cellular interactions by inhibiting cell adhesion. 1 There is growing evidence that NO is critically involved in obesity and its clinical consequences like cardiovascular disease, hypertension and diabetes. [2] [3] [4] It is hypothesized that obesity-related oxidative stress reduces the bioavailability of NO. 5, 6 Decreased bioavailability of NO may result in impaired endothelium-dependent vasodilatation and promotes atherosclerosis. Several mediators and mechanisms are discussed to be involved, including parameters of the glucose and lipid metabolism. Further, inflammatory markers [7] [8] [9] and adipocytokines like adiponectin, resistin and leptin may also be involved. 10 Elevated leptin and homocysteine concentrations in obese individuals with and without hypertension induce oxidative stress, which leads to a free-radical-induced decrease of NO. [11] [12] [13] [14] Experimental data suggest also an involvement of the neurological GABAergic system in obesity and related disorders. 15 Activation of the sympathetic nervous system, especially via g-aminobutyric acid (GABA) contributes to the pathogenesis of obesity-induced hypertension. 16 We hypothesize that NO is already involved in the pathophysiology of juvenile obesity and may contribute to atherogenesis. We here determined the role of NO and its metabolites arginine and citrulline in obese and normal weight children. Further, we investigated a possible involvement of NO in inflammation, in the glucose and lipid metabolism and examined correlations between NO, adipocytokines, GABA and homocysteine.
Materials and methods

Patients
We investigated 57 obese and 57 normal weight age-and gender-matched juveniles at the Clinical Institute of Medical and Chemical Laboratory Diagnostics and Department of Pediatrics, Medical University of Graz. Obesity was defined as a body mass index (BMI) value greater than the 97th percentile. Obese subjects attended the clinics in seek for dietary advice. The normal weight control persons came for minor surgical interventions and were otherwise healthy. Exclusion criteria were growth abnormalities and thyroidal dysfunctions.
Blood collection
Blood collection was performed after written informed consent was given. At the time of blood collection all probands were fasting and free of common infectious diseases. Blood was obtained by venous puncture, immediately centrifuged at ambient temperature and stored at À80 1C until analysis.
Carotid artery ultrasound
The bulbus near common carotid arteries on both sides were scanned with a 12-5 MHz broadband linear transducer on a HDI 5000 (ATL, Bothell, Washington, DC, USA). Longitudinal images directed through the center of the artery were taken at each vessel site. Measurements were made from stored digital images by an experienced reader. The intima media thickness (IMT) was assessed at the far wall as the distance between the interface of the lumen and intima, and the interface between the media and adventitia. The maximal IMT was recorded at each of the vessel segments and averaged for the left and right carotid artery. The lumen diameter was calculated as the inter-adventitial diameter minus twice the maximum far wall IMT. All diameters were obtained during the diastole to avoid image blurring due to systolic arterial wall motion, and to minimize the influence of blood pressure.
Laboratory procedures
Glucose (hexokinase method), cholesterol and triglycerides (TG) were measured enzymatically (Roche Diagnostics, Mannheim, Germany). Lipoproteins were separated by b-quantification. C-reactive protein (CRP) was measured with a particle-enhanced immunoturbidimetric assay (Tinaquant, C-reactive protein ultra sensitive assay, Roche Diagnostics). Insulin was determined by radioimmunoassay (INSI-CTK IRMA; Sorin Diagnostics, Düsseldorf, Germany). Homocysteine was analyzed by triple quadrupole mass spectrometry (Applied Biosystems, Brunn am Gebirge, Austria API 2000 LC/MS/MS system) using a 3.3 Â 0.46 cm high pressure liquid chromatography column (Supelco LC-CN). Homeostasis model assessment (HOMA) index was calculated as follows: (fasting glucose (mmol l À1 ) Â fasting insulin (UE ml À1 ))/22.5. Resistin (Biovendor, Modrice, Czech Republic), leptin (Mercodia, Uppsala, Sweden), leptin receptor (Mercodia), interleukine 6 (IL-6) (BenderMedSystems, Vienna, Austria) and oxidized low-density lipoprotein (LDL, Mercodia) were determined by commercial enzyme-linked immunosorbent assay. NOX, as the sum of nitrate and nitrite was determined with the NO Quantification Kit from ActiveMotif, Rixensart, Belgium. Arginine, citrulline, histamine, GABA and cystathionine were determined by triple quadrupole mass spectrometry (Applied Biosystems, API 2000 LC/MS/MS system) with the EZ:Faast Amino Acid Kit from Phenomenex, Aschaffenburg, Germany.
Statistical analysis
Results are presented as means ± standard deviations. Continuous variables were compared using Student's t-test for independent samples or Mann-Whitney U-test depending on the contribution of data. Correlations between variables were determined by linear regression analysis according to Pearson's and subsequent multiple regression analysis. P-values less than 0.05 were considered statistically significant. Analyses were performed using SPSS for Windows ( Figure 1 ).
Statement of ethics
We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research. The study was approved by the ethics committee of the Medical University of Graz.
Results
Study participants
Baseline characteristics of obese and normal weight children are shown in Table 1 Nitric oxide in obese children H-J Gruber et al 0.42±0.97, respectively. Obese juveniles showed a significant increase in systolic blood pressure (Po0.001). Further, IMT was also significantly increased (Po0.0001). The lipid status of obese juveniles revealed a significant decrease in high-density lipoprotein (HDL) cholesterol (P ¼ 0.005) and an increase in cholesterol (P ¼ 0.001), TG (Po0.0001), very low density lipoprotein (VLDL) cholesterol (P ¼ 0.032) and LDL cholesterol (P ¼ 0.005). Further, obese juveniles showed increased insulin (P ¼ 0.01) and HOMA index levels (P ¼ 0.005). Fasting glucose did not differ between the groups. Inflammation-associated biomarkers like CRP (Po0.0001) and IL-6 (Po0.0001) were highly significantly increased in obese juveniles. Homocysteine and oxidized LDL cholesterol levels were also increased, but did not reach statistical significance. We further investigated amino acids associated with the NO pathway. Histamine and cystathionine showed no significant differences between obese and normal weight children. GABA (Po0.0001) was highly significantly increased. The analysis of adipokines revealed a not significant decrease in adiponectin levels in obese juveniles. Leptin was highly significantly increased (Po0.0001) and leptin receptor values were significantly decreased (P ¼ 0.003). Resistin showed no differences between obese and normal weight children.
Analysis of the NO pathway showed significant alterations in obese compared to normal weight children. NOX (Po0.0001) and its metabolites nitrate (Po0.0001) and nitrite (Po0.0001) were highly significantly decreased in obese juveniles. NOX showed no gender effect, neither in the obese group (P ¼ 0.705) nor in the normal weight group (P ¼ 0.273). Arginine (Po0.0001) was highly significantly increased and citrulline (Po0.0001) highly significantly decreased.
Correlations of the NO pathway with obesity, age, lipid metabolism, inflammation and insulin resistance Parameters of the NO pathway, like NOX and the associated amino acids arginine and citrulline were analyzed by linear regression analysis (Table 2 ) and subsequent multiple comparison (Table 3) Table 2 did not remain significant in multiple testing. Multiple regression analysis of citrulline revealed significant negative correlations with BMI (b ¼ À0.235/P ¼ 0.009) glucose (b ¼ À0.181/ P ¼ 0.039) and GABA (b ¼ À0.287/P ¼ 0.002). As mentioned above, the correlation of citrulline with NOX was not robust in multiple testing.
Discussion
We show here that NOX was highly significantly decreased in obese juveniles compared to normal weight juveniles. 
Nitric oxide in obese children H-J Gruber et al
Further, NOX significantly negatively correlated with body weight. Moreover, arginine was highly significantly increased in obese juveniles and positively correlated with body weight. Citrulline was highly significantly decreased and negatively correlated with BMI. Interestingly, neither arginine nor citrulline showed robust correlations with NOX. Our findings are in the line with other studies, which implicate an association between obesity and decreased bioavailability of NO. 17, 18 Taken together, we show here, that the bioavailability of NOX is already diminished in obese juveniles with a mean age of 14 years and that the amino acids arginine and citrulline of the NO syntheses pathway are involved in obesity. It is hypothesized that obesity induces oxidative stress that leads to a free-radicalinduced decrease in NOX. Superoxide produced in the vascular wall may inhibit NO-mediated endothelial function by reacting with NO, forming peroxynitrite, a cytotoxic substance. 19, 20 Obesity-induced oxidative stress may also be responsible for our observation that NOX negatively correlates with oxidized LDL. However, the increase in oxidized LDL values in obese juveniles compared to normal weight juveniles did not reach statistical significance. The finding that NOX significantly negatively correlated with oxidized LDL may be of clinical relevance, as oxidized LDL is involved in atherogenesis. One may speculate that reduced NOX bioavailability may, at least in part, mediate atherogenesis via its correlation with oxidized LDL. However, no correlation between NOX and IMT, as a marker of atherosclerosis was found in our cohort. Superoxide can be produced from endothelial NO synthase (eNOS), transforming eNOS from a protective enzyme to a contributor of oxidative stress. 21 Superoxide production of eNOS occurs under conditions of diminished availability of the substrate L-arginine or of the essential cofactor tetrahydrobiopterin. 22 The effects of the substrate L-arginine on NO production are described as the 'arginine paradox', as extracellular L-arginine seems to drive NO synthesis despite an excess of intracellular L-arginine. 23 We found an increase in arginine values and a decrease in citrulline, indicating that obesity-induced reduction of NOX is not mediated via diminished arginine. The underlying mechanism may therefore not include eNOS as a source of superoxide production. One may speculate that obesityrelated low-grade inflammation, as indicated by increased CRP and IL-6 values induces radical oxygen species production in inflammatory cells. 24 However, despite a not robust correlation between NOX and CRP, we found no significant Nitric oxide in obese children H-J Gruber et al correlations between inflammatory markers and the NO pathway. The attenuated NO production in obese individuals may also be affected by hypertension. Obesity and related essential hypertension seem to be independently involved in this mechanism. The combination of obesity and hypertension has additive effects on endothelium-dependent vasodilation. 5 We found a significant increase in systolic blood pressure in obese juveniles, but no robust correlations between blood pressure and NOX or arginine or citrulline. This suggests that hypertension in juveniles is not necessarily involved in obesity-related NOX reduction. Analysis of lipid parameters revealed an atherogenic lipid profile in obese juveniles. However, no significant correlations between NOX, arginine or citrulline and lipid parameters were found. We further investigated the role of adipocytokines in obesity-related NOX reduction. First, we analyzed the role of leptin and leptin receptor, as an association between leptin and NOX had been shown in nonobese normotensive men. 25 We found significant increased leptin values and decreased leptin receptor levels in obese juveniles, but we did not find any robust correlations between leptin and parameters of the NO pathway. Our findings are in the line with Konukoglu et al. 11 who have shown that in obese women, with or without hypertension, no association of NOX with leptin was found. In this study, Konukoglu et al.
describe an association between increased leptin values and oxidative stress in obese women, further indicating that obesity-related modulations of the NO pathway seem to be driven by oxidative stress. Second, we examined an involvement of adiponectin and resistin. Obese juveniles showed a decrease in adiponectin and an increase in resistin values, which did not reach statistical significance. Neither NOX nor citrulline showed significant correlations with these adipocytokines. A highly significant negative correlation was found between arginine and resistin. Resistin is involved as mediator in insulin resistance, whereas adiponectin is ascribed as an insulin sensitizer. 26-28 Thus, we investigated further possible interactions with the glucose metabolism. Arginine showed a positive correlation with insulin, which was significantly increased in obese juveniles. Furthermore, citrulline negatively correlated with glucose, which showed similar values between obese and normal weight children. However, NOX showed no correlation with parameters of the glucose metabolism. Taken together, arginine and citrulline revealed correlations with parameters of the glucose metabolism, suggesting an involvement in resistinmediated insulin resistance in obese individuals. Current studies discuss also an involvement of homocysteine in the NO pathway. 13 We found no significant alterations in homocysteine levels between obese and normal weight juveniles nor did we find any correlation with the NO pathway in our cohort. The effects of homocysteine on oxidative stress and NO are ascribed to patients' hyperhomocysteinemia. 14 The fact that obese juveniles did not show hyperhomocysteinemia may explain that no correlations with the NO pathway were found. As homocysteine can be converted to cystathionine by the heme and pyridoxal phosphate-dependent cystathionine b-synthase, we also investigated the role of cystathionine. Similar to homocysteine, we found no differences in cystathionine levels between obese and normal weight juveniles. NOX and citrulline showed no correlations with cystathionine. Interestingly, we found a positive correlation between cystathionine and arginine. The correlation between cystathionine and arginine may be explained by the metabolic pathways of homocysteine including cystathionine and arginine. 29, 30 There is raising evidence that the neurological GABAergic system may also be involved in obesity and related disorders. 15 Especially, altered GABAergic neurotransmission may play a role in the metabolic syndrome and cardiovascular regulation. 31 Further, GABA serves as a functional regulator of pancreatic hormone release and activation of the sympathetic nervous system, contributing to the pathogenesis of obesity-induced hypertension. 16, 32 Therefore we investigated the role of GABA in obesity-related NOX reduction. We found highly significantly increased GABA levels in obese juveniles and a significant negative correlation with NOX and citrulline. GABA positively correlated with arginine, which did not remain significant in multiple testing. An involvement of GABA in obesity is supported by our finding that GABA highly significantly correlated with BMI in our cohort (Po0.001/r ¼ 0.314). To our knowledge, this is the first study that indicates a role of GABA in juvenile obesity-related reduced NOX bioavailability. This may be of clinical relevance, as the correlation between GABA and the NO pathway may represent a crossing point between neurological and metabolic changes in obesity and related disorders. In summary, we show here that NO is already involved in juvenile obesity and may contribute to atherogenesis via reduced bioavailability of NO and oxidized LDL cholesterol. The amino acids of NO synthesis, arginine and citrulline reveal no clear correlation with NO. However, both correlate with obesity and with parameters of the glucose metabolism, suggesting an involvement in obesity-related insulin resistance. Moreover, we identify GABA as a new parameter in the mechanism of obesity-related NO reduction.
